BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

238 related articles for article (PubMed ID: 20613716)

  • 1. A 'complexity' of urate transporters.
    Wright AF; Rudan I; Hastie ND; Campbell H
    Kidney Int; 2010 Sep; 78(5):446-52. PubMed ID: 20613716
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Recent advances in renal urate transport: characterization of candidate transporters indicated by genome-wide association studies.
    Anzai N; Jutabha P; Amonpatumrat-Takahashi S; Sakurai H
    Clin Exp Nephrol; 2012 Feb; 16(1):89-95. PubMed ID: 22038265
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Urate transporters: an evolving field.
    Anzai N; Endou H
    Semin Nephrol; 2011 Sep; 31(5):400-9. PubMed ID: 22000646
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The genetics of hyperuricaemia and gout.
    Reginato AM; Mount DB; Yang I; Choi HK
    Nat Rev Rheumatol; 2012 Oct; 8(10):610-21. PubMed ID: 22945592
    [TBL] [Abstract][Full Text] [Related]  

  • 5. SLC2A9 is a high-capacity urate transporter in humans.
    Caulfield MJ; Munroe PB; O'Neill D; Witkowska K; Charchar FJ; Doblado M; Evans S; Eyheramendy S; Onipinla A; Howard P; Shaw-Hawkins S; Dobson RJ; Wallace C; Newhouse SJ; Brown M; Connell JM; Dominiczak A; Farrall M; Lathrop GM; Samani NJ; Kumari M; Marmot M; Brunner E; Chambers J; Elliott P; Kooner J; Laan M; Org E; Veldre G; Viigimaa M; Cappuccio FP; Ji C; Iacone R; Strazzullo P; Moley KH; Cheeseman C
    PLoS Med; 2008 Oct; 5(10):e197. PubMed ID: 18842065
    [TBL] [Abstract][Full Text] [Related]  

  • 6. GLUT9 influences uric acid concentration in patients with Lesch-Nyhan disease.
    Torres RJ; Puig JG
    Int J Rheum Dis; 2018 Jun; 21(6):1270-1276. PubMed ID: 29879316
    [TBL] [Abstract][Full Text] [Related]  

  • 7. An update on the genetic architecture of hyperuricemia and gout.
    Merriman TR
    Arthritis Res Ther; 2015 Apr; 17(1):98. PubMed ID: 25889045
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Human sodium phosphate transporter 4 (hNPT4/SLC17A3) as a common renal secretory pathway for drugs and urate.
    Jutabha P; Anzai N; Kitamura K; Taniguchi A; Kaneko S; Yan K; Yamada H; Shimada H; Kimura T; Katada T; Fukutomi T; Tomita K; Urano W; Yamanaka H; Seki G; Fujita T; Moriyama Y; Yamada A; Uchida S; Wempe MF; Endou H; Sakurai H
    J Biol Chem; 2010 Nov; 285(45):35123-32. PubMed ID: 20810651
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Plasma urate level is directly regulated by a voltage-driven urate efflux transporter URATv1 (SLC2A9) in humans.
    Anzai N; Ichida K; Jutabha P; Kimura T; Babu E; Jin CJ; Srivastava S; Kitamura K; Hisatome I; Endou H; Sakurai H
    J Biol Chem; 2008 Oct; 283(40):26834-8. PubMed ID: 18701466
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Common polymorphisms influencing serum uric acid levels contribute to susceptibility to gout, but not to coronary artery disease.
    Stark K; Reinhard W; Grassl M; Erdmann J; Schunkert H; Illig T; Hengstenberg C
    PLoS One; 2009 Nov; 4(11):e7729. PubMed ID: 19890391
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Complex analysis of urate transporters SLC2A9, SLC22A12 and functional characterization of non-synonymous allelic variants of GLUT9 in the Czech population: no evidence of effect on hyperuricemia and gout.
    Hurba O; Mancikova A; Krylov V; Pavlikova M; Pavelka K; Stibůrková B
    PLoS One; 2014; 9(9):e107902. PubMed ID: 25268603
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Urate transporters in the genomic era.
    Sakurai H
    Curr Opin Nephrol Hypertens; 2013 Sep; 22(5):545-50. PubMed ID: 23852331
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The genetic basis of hyperuricaemia and gout.
    Merriman TR; Dalbeth N
    Joint Bone Spine; 2011 Jan; 78(1):35-40. PubMed ID: 20472486
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Trans-ancestral dissection of urate- and gout-associated major loci SLC2A9 and ABCG2 reveals primate-specific regulatory effects.
    Takei R; Cadzow M; Markie D; Bixley M; Phipps-Green A; Major TJ; Li C; Choi HK; Li Z; Hu H; ; Guo H; He M; Shi Y; Stamp LK; Dalbeth N; Merriman TR; Wei WH
    J Hum Genet; 2021 Feb; 66(2):161-169. PubMed ID: 32778763
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Association of four genetic loci with uric acid levels and reduced renal function: the J-SHIPP Suita study.
    Tabara Y; Kohara K; Kawamoto R; Hiura Y; Nishimura K; Morisaki T; Kokubo Y; Okamura T; Tomoike H; Iwai N; Miki T
    Am J Nephrol; 2010; 32(3):279-286. PubMed ID: 20714133
    [TBL] [Abstract][Full Text] [Related]  

  • 16. ABCG2 rs2231142 variant in hyperuricemia is modified by SLC2A9 and SLC22A12 polymorphisms and cardiovascular risk factors in an elderly community-dwelling population.
    Liu J; Yang W; Li Y; Wei Z; Dan X
    BMC Med Genet; 2020 Mar; 21(1):54. PubMed ID: 32183743
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Genetics of hyperuricemia and gout: implications for the present and future.
    George RL; Keenan RT
    Curr Rheumatol Rep; 2013 Feb; 15(2):309. PubMed ID: 23307580
    [TBL] [Abstract][Full Text] [Related]  

  • 18. SLC2A9 is a newly identified urate transporter influencing serum urate concentration, urate excretion and gout.
    Vitart V; Rudan I; Hayward C; Gray NK; Floyd J; Palmer CN; Knott SA; Kolcic I; Polasek O; Graessler J; Wilson JF; Marinaki A; Riches PL; Shu X; Janicijevic B; Smolej-Narancic N; Gorgoni B; Morgan J; Campbell S; Biloglav Z; Barac-Lauc L; Pericic M; Klaric IM; Zgaga L; Skaric-Juric T; Wild SH; Richardson WA; Hohenstein P; Kimber CH; Tenesa A; Donnelly LA; Fairbanks LD; Aringer M; McKeigue PM; Ralston SH; Morris AD; Rudan P; Hastie ND; Campbell H; Wright AF
    Nat Genet; 2008 Apr; 40(4):437-42. PubMed ID: 18327257
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Pharmacological Evaluation of Dotinurad, a Selective Urate Reabsorption Inhibitor.
    Taniguchi T; Ashizawa N; Matsumoto K; Saito R; Motoki K; Sakai M; Chikamatsu N; Hagihara C; Hashiba M; Iwanaga T
    J Pharmacol Exp Ther; 2019 Oct; 371(1):162-170. PubMed ID: 31371478
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Deciphering genetic signatures by whole exome sequencing in a case of co-prevalence of severe renal hypouricemia and diabetes with impaired insulin secretion.
    Sekiya M; Matsuda T; Yamamoto Y; Furuta Y; Ohyama M; Murayama Y; Sugano Y; Ohsaki Y; Iwasaki H; Yahagi N; Yatoh S; Suzuki H; Shimano H
    BMC Med Genet; 2020 May; 21(1):91. PubMed ID: 32375679
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 12.